… The current study focused on the long-term safety and tolerability of valsartan along with
the efficacy in paediatric patients aged 6 to 17 years with or without CKD. Most …

… safety issues. We aimed to summarize the available evidence regarding sacubitril-valsartan’s
safety and tolerability. … that sacubitril-valsartan was at least as safe and tolerable as the …

… compared with those of olmesartan are not well established in Japanese patients with …
efficacy and safety of sacubitril/valsartan in Japanese patients with mild to moderate essential …

… efficacy and safety of angiotensin receptor neprilysin inhibitor sacubitril/valsartan vs olmesartan
in Asian patients with mild-… The safety profile of sacubitril/valsartan reported in this study …

… to those of olmesartan in patients with HTN. In our study, we aim to compare the safety
and efficacy of sacubitril/valsartan versus olmesartan in patients with HTN. …

… , we aimed to assess the BP-lowering efficacy as well as the safety of sacubitril/valsartan in
patients with chronic TBAD combined with mild hypertension compared with valsartan alone. …

… were more efficacious than other agents on central hemodynamics. … /valsartan combination
reached its maximum efficacy in … The amlodipine/valsartan combination has been studied …

… Safety and adverse events The safety and tolerability of valsartan were similar to placebo.
Compared to placebo, average systolic blood pressure decreased by 3 mmHg (P = 0.07) and …

… This study was done to determine the efficacy of amlodipine/valsartan (Aml/Val) once-daily …
, tolerability, as well as effectiveness, were after eight weeks of treatment; 92.7% of patients in …

… valsartan to evaluate which has superior efficacy in reducing BP among mild-to-moderate
Korean hypertensive patients… losartan, valsartan, and irbesartan to evaluate their efficacy in the …